Last reviewed · How we verify

Ibuprofen, brimonidine, latanoprost

Philadelphia Eye Associates · Phase 1 active Small molecule

Ibuprofen, brimonidine, latanoprost is a Small molecule drug developed by Philadelphia Eye Associates. It is currently in Phase 1 development. Also known as: ibuprofen 200mg, and placebo pills.

At a glance

Generic nameIbuprofen, brimonidine, latanoprost
Also known asibuprofen 200mg, and placebo pills
SponsorPhiladelphia Eye Associates
ModalitySmall molecule
PhasePhase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Ibuprofen, brimonidine, latanoprost

What is Ibuprofen, brimonidine, latanoprost?

Ibuprofen, brimonidine, latanoprost is a Small molecule drug developed by Philadelphia Eye Associates.

Who makes Ibuprofen, brimonidine, latanoprost?

Ibuprofen, brimonidine, latanoprost is developed by Philadelphia Eye Associates (see full Philadelphia Eye Associates pipeline at /company/philadelphia-eye-associates).

Is Ibuprofen, brimonidine, latanoprost also known as anything else?

Ibuprofen, brimonidine, latanoprost is also known as ibuprofen 200mg, and placebo pills.

What development phase is Ibuprofen, brimonidine, latanoprost in?

Ibuprofen, brimonidine, latanoprost is in Phase 1.

Related